Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report

Oncology Letters

Volumn 7, Issue 5, 2014, Pages 1497-1498

  Chang, Pei Hung ^a   Wang, Mei Ti ^b   Chen, Yi Hua ^b   Chen, Yu Ying ^b   Wang, Cheng Hsu ^a,c  

^a Division of Hemato Oncology Department of Internal Medicine   (Taiwan)

^b Department of Pharmacy ^*  (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chemotherapy; Docetaxel; Extravasation

Indexed keywords

CHLORPHENIRAMINE; DEXAMETHASONE; DOCETAXEL; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DRUG EXTRAVASATION; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; MIDDLE AGED; PAGET NIPPLE DISEASE; PAIN; RANGE OF MOTION; RELAPSE; SKIN EXFOLIATION; SKIN INJURY; SKIN PRURITUS; SKIN SWELLING;

EID: 84896290585     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1921     Document Type: Article

References (8)

1. Bronner AK and Hood AF: Cutaneous complications of chemotherapeutic agents. J Am Acad Dermatol 9: 645-663, 1983.
2. Albanell J and Baselga J: Systemic therapy emergencies. Semin Oncol 27: 347-361, 2000.
3. Raley J, Geisler JP, Buekers TE and Sorosky JI: Docetaxel extravasation causing significant delayed tissue injury. Gynecol Oncol 78: 259-260, 2000.
4. Ener RA, Meglathery SB and Styler M: Extravasation of systemic hemato-oncological therapies. Ann Oncol 15: 858-862, 2004.
5. Ho CH, Yang CH and Chu CY: Vesicant-type reaction due to docetaxel extravasation. Acta Derm Venereol 83: 467-468, 2003.
6. Susser WS, Whitaker-Worth DL and Grant-Kels JM: Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 40: 367-398, 1999.
7. Una E, Cuadrillero F and Lopez-Lara F: Drug extravasation: a dreaded complication. BMJ Case Rep 2009: bcr09.2008.0887, 2009.
8. Ascherman JA, Knowles SL and Attkiss K: Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations. Ann Plast Surg 45: 438-441, 2000.